Vasiliy A. Petrukhin

Vasiliy A. Petrukhin

Auto-generated profile, based on publicly available information

Vasiliy A. Petrukhin

M.F. Vladimirsky Moscow Regional Scientific Research Clinical Institute

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2019 in Annals of Critical Care
Verified
Journal Article
Open access
ESE. M. Shifman
E. M. Shifman
AKA. V. Kulikov
A. V. Kulikov
ARAlexander M. Ronenson
Alexander M. Ronenson
IAI. S. Abazova
I. S. Abazova
LAL. V. Adamyan
L. V. Adamyan
IZI. B. Zabolotskikh
I. B. Zabolotskikh
The article observes the main provisions of the clinical recommendations for prevention, anesthesia and intensive care for postpartum hemorrhage. The main risk factors, possible complications, principles of clinical and laboratory diagnosis in this pathology are consistently presented. Particular attention is paid to issues of infusion, transfusion therapy and correction of coagulopathic disorders. The problems of estimating the amount of blood loss, diagnosing disorders of the hemostatic system, regulation of hemodynamics in hemorrhagic shock are discussed. The use of recombinant coagulation factors in coagulopathy on the background of massive blood loss has been substantiated.

26 March 2025 in Bulletin of Reproductive Health
Verified
Journal Article
Open access
PDF file
EAE. N. Andreeva
E. N. Andreeva
NAN. Yu. Arbatskaya
N. Yu. Arbatskaya
OAO. N. Arzhanova
O. N. Arzhanova
NBN. V. Bashmakova
N. V. Bashmakova
NBN. V. Borovik
N. V. Borovik
НАН. Ю. Арбатская
Н. Ю. Арбатская
The present article contains the newest ant the most actual version of clinical recommendations “Gestational diabetes mellitus” of the Russian Ministry of Health. This document has been confirmed for the period from 2024 until 2026 year. Gestational diabetes mellitus is widely known as onset of hyperglycaemia during pregnancy that does not responds to criteria of manifesting diabetes mellitus (DM). The time of next revision is 2026 year or earlier if new evidentiary material appear. The present version of clinical recommendation has been created due to collaboration between Russian Association of Endocrinologists and Russian Society of Obstetricians and Gynecologists. The document is finally approved by scientific and practical Council of the Russian Ministry of Health.

21 May 2018 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
Natalia V. ZubkovaNatalia V. Zubkova
Natalia V. Zubkova
FBFatima F. Burumkulova
Fatima F. Burumkulova
VUVictoria I. Ulyatovskaya
Victoria I. Ulyatovskaya
VPVasily A. Petrukhin
Vasily A. Petrukhin
MPMargarita A. Plechanova
Margarita A. Plechanova
ТНТюльпаков Анатолий Николаевич
Тюльпаков Анатолий Николаевич
Background. Gestational diabetes (GDM) due to GCK gene mutations is the most frequent form of monogenic diabetes mellitus (DM) presenting during pregnancy. It has been suggested that the use of insulin in pregnancies with fetuses carrying GCK mutations may lead to intrauterine growth retardation. In the present study we evaluated the effect of insulin therapy during pregnancy on birth weight and length in the offsprings of mothers with GDM due to GCK mutations. Aims. The aim was to study birth weight and length in offsprings of mothers with gestational diabetes mellitus due to mutations in GCK, depending on the therapy during pregnancy. Materials and methods. The study included 38 patients with GDM caused by GCK gene mutations (18.7%) and the 45 offsprings. To define molecular basis of GDM in pregnant women we used a targeted NGS. Diabetes panel genes were sequenced using a custom Ion Ampliseq gene panel and PGM semiconductor sequencer (Ion Torrent). To found the same mutations in their offsprings was used Sanger sequencing. All children were divided into 3 groups depending of their genotype and therapy received by the mothers during pregnancy. Results. We found statistically significant differences in birth length (p=0.04) and weight (p=0,031) depending on the genotype of the child and therapy in the mother. The risk of macrosomia was shown in non-mutation-carrying offsprings only. The birth weight in children with GCK gene mutations whose mothers received insulin during pregnancy was significantly lower. However, the birth weight remained in the normal range. Conclusions. Since prenatal diagnostics in the mothers with GCK gene mutations is not always justified, we recommend insulin therapy in order to prevent fetal macrosomia, which, however, should be less aggressive than in GDM due to other causes.

1 January 2018 in Russian Journal of Archive of Pathology
Verified
Journal Article
Closed access
PDF file
IBI. V. Barinova
I. V. Barinova
NKN. I. Kondrikov
N. I. Kondrikov
IVI. N. Voloshchuk
I. N. Voloshchuk
MCM. A. Chechneva
M. A. Chechneva
NSN. A. Shchukina
N. A. Shchukina
VPV. A. Petrukhin
V. A. Petrukhin
In most cases, placental localization in the scar after cesarean section is accompanied by abnormal placental attachment: placenta accreta, less frequently in combination with its ingrowth (placenta accreta/increta).

27 August 2017 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
KKKrasnopolsky V.I. Krasnopolsky
Krasnopolsky V.I. Krasnopolsky
LLLogutova L.S. Logutova
Logutova L.S. Logutova
AAAkhvlediani K.N. Akhvlediani
Akhvlediani K.N. Akhvlediani
TATravkina A.A. Travkina A
Travkina A.A. Travkina A
PPPetrukhin V.A. Petrukhin
Petrukhin V.A. Petrukhin
MAMelnikov A.P. Melnikov A
Melnikov A.P. Melnikov A

20 October 2020 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
ZZZemskova N.YU. Zemskova
Zemskova N.YU. Zemskova
CCChechneva M.A. Chechneva
Chechneva M.A. Chechneva
PPPetrukhin V.A. Petrukhin
Petrukhin V.A. Petrukhin
LLLukashenko S.YU. Lukashenko
Lukashenko S.YU. Lukashenko